American Caresource (OTCMKTS:GNOW) and Caladrius Biosciences (NASDAQ:CLBS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends.
Institutional & Insider Ownership
7.6% of Caladrius Biosciences shares are owned by institutional investors. 51.5% of American Caresource shares are owned by company insiders. Comparatively, 7.5% of Caladrius Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
This table compares American Caresource and Caladrius Biosciences’ top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|American Caresource||$10.02 million||0.01||-$13.30 million||N/A||N/A|
|Caladrius Biosciences||$35.28 million||1.16||$22.97 million||($1.78)||-2.33|
Caladrius Biosciences has higher revenue and earnings than American Caresource.
This table compares American Caresource and Caladrius Biosciences’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Risk & Volatility
American Caresource has a beta of 3.86, indicating that its stock price is 286% more volatile than the S&P 500. Comparatively, Caladrius Biosciences has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500.
This is a breakdown of recent ratings and price targets for American Caresource and Caladrius Biosciences, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Caladrius Biosciences has a consensus target price of $12.75, indicating a potential upside of 207.23%. Given Caladrius Biosciences’ higher possible upside, analysts plainly believe Caladrius Biosciences is more favorable than American Caresource.
Caladrius Biosciences beats American Caresource on 6 of the 10 factors compared between the two stocks.
About American Caresource
American CareSource Holdings, Inc. provides urgent and primary care services in the United States. The company operates healthcare centers that offer non-life-threatening out-patient medical care for the treatment of acute, episodic, and chronic medical conditions. Its healthcare centers provide treatment of general medical problems, including colds, flus, ear infections, hypertension, asthma, pneumonia, urinary tract infections, and other conditions; treatment of injuries, such as fractures, dislocations, sprains, bruises, and cuts; minor non-emergent surgical procedures; diagnostic tests, such as X-rays, electrocardiograms, complete blood counts, and urinalyses; and occupational and industrial medical services, including drug testing, workers' compensation cases, and pre-employment physical examinations. It owns and operates 13 urgent and primary care centers, including 2 in Georgia, 2 in Florida, 3 in Alabama, 4 in North Carolina, and 2 in Virginia. The company was founded in 1995 and is headquartered in Atlanta, Georgia.
About Caladrius Biosciences
Caladrius Biosciences, Inc. operates as a global healthcare company, which engages in developing cellular therapies that repair damaged tissue, cells and organs and restore their normal function. It is pursuing the preservation and enhancement of human health globally through the development of cell based therapeutics that prevent, treat or cure disease. Its business includes the development of novel proprietary cell therapy products, as well as a revenue-generating contract development and manufacturing service business that it leverages for the development of therapeutics while providing service to other companies in the cell therapy industry developing products. The company was founded in September 1980 and is headquartered in New York, NY.
Receive News & Ratings for American Caresource Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Caresource and related companies with MarketBeat.com's FREE daily email newsletter.